Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07814781Completed
Randomised, single-blind trial in episiotomy (2 arms), sponsored by Hamad Medical Corporation. Primary endpoint: REEDA Score at 12 days. Started Dec 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07814781.